QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis
NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to QDEL. QDEL was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While QDEL is still in line with the averages on profitability rating, there are concerns on its financial health. QDEL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QDEL was profitable.
In the past year QDEL had a positive cash flow from operations.
In multiple years QDEL reported negative net income over the last 5 years.
QDEL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.55%, QDEL is in the better half of the industry, outperforming 65.43% of the companies in the same industry.
The Return On Equity of QDEL (-11.97%) is better than 65.96% of its industry peers.
QDEL has a better Return On Invested Capital (1.25%) than 69.15% of its industry peers.
QDEL had an Average Return On Invested Capital over the past 3 years of 4.37%. This is below the industry average of 7.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.55% | ||
| ROE | -11.97% | ||
| ROIC | 1.25% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
1.3 Margins
QDEL has a better Operating Margin (3.11%) than 69.15% of its industry peers.
QDEL's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 46.94%, QDEL is in line with its industry, outperforming 40.43% of the companies in the same industry.
QDEL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 46.94% |
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
Compared to 1 year ago, QDEL has more shares outstanding
QDEL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, QDEL has a worse debt to assets ratio.
2.2 Solvency
QDEL has an Altman-Z score of 0.90. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, QDEL is in line with its industry, outperforming 48.40% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that QDEL is somewhat dependend on debt financing.
The Debt to Equity ratio of QDEL (0.70) is worse than 69.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.9 |
ROIC/WACC0.17
WACC7.26%
2.3 Liquidity
QDEL has a Current Ratio of 1.20. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.20, QDEL is not doing good in the industry: 82.98% of the companies in the same industry are doing better.
QDEL has a Quick Ratio of 1.20. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of QDEL (0.66) is worse than 90.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
The earnings per share for QDEL have decreased strongly by -22.38% in the last year.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
The Revenue has decreased by -3.42% in the past year.
The Revenue has been growing by 39.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
3.2 Future
Based on estimates for the next years, QDEL will show a very strong growth in Earnings Per Share. The EPS will grow by 28.34% on average per year.
QDEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.57% yearly.
EPS Next Y31.06%
EPS Next 2Y33.47%
EPS Next 3Y33.08%
EPS Next 5Y28.34%
Revenue Next Year-2.33%
Revenue Next 2Y0.9%
Revenue Next 3Y2.28%
Revenue Next 5Y2.57%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.27, which indicates a correct valuation of QDEL.
Based on the Price/Earnings ratio, QDEL is valued cheaper than 86.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.25, QDEL is valued a bit cheaper.
With a Price/Forward Earnings ratio of 9.31, the valuation of QDEL can be described as very reasonable.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaply inside the industry as 93.62% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, QDEL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.27 | ||
| Fwd PE | 9.31 |
4.2 Price Multiples
QDEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QDEL is cheaper than 94.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.38 |
4.3 Compensation for Growth
QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as QDEL's earnings are expected to grow with 33.08% in the coming years.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y33.47%
EPS Next 3Y33.08%
5. Dividend
5.1 Amount
No dividends for QDEL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.67
-0.08 (-0.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.74%
Inst Owner Change3.24%
Ins Owners0.49%
Ins Owner Change0.78%
Market Cap2.07B
Analysts76
Price Target54.35 (77.21%)
Short Float %6.4%
Short Ratio2.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.18%
Min EPS beat(2)4.59%
Max EPS beat(2)23.78%
EPS beat(4)4
Avg EPS beat(4)65.27%
Min EPS beat(4)4.59%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)33.31%
EPS beat(12)9
Avg EPS beat(12)36.06%
EPS beat(16)12
Avg EPS beat(16)30.37%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.75%
Revenue beat(4)2
Avg Revenue beat(4)2.64%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)11.02%
Revenue beat(8)5
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)1.78%
Revenue beat(16)11
Avg Revenue beat(16)4.61%
PT rev (1m)-0.27%
PT rev (3m)-0.27%
EPS NQ rev (1m)-93.75%
EPS NQ rev (3m)-95.11%
EPS NY rev (1m)0.87%
EPS NY rev (3m)-0.71%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-3.52%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)-2.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.27 | ||
| Fwd PE | 9.31 | ||
| P/S | 0.75 | ||
| P/FCF | N/A | ||
| P/OCF | 13.89 | ||
| P/B | 0.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.38 |
EPS(TTM)2.15
EY7.01%
EPS(NY)3.3
Fwd EY10.75%
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)2.21
OCFY7.2%
SpS40.88
BVpS44.32
TBVpS-5.49
PEG (NY)0.46
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.55% | ||
| ROE | -11.97% | ||
| ROCE | 1.59% | ||
| ROIC | 1.25% | ||
| ROICexc | 1.28% | ||
| ROICexgc | 3.54% | ||
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 46.94% | ||
| FCFM | N/A |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.96 | ||
| Cap/Depr | 41.56% | ||
| Cap/Sales | 6.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 0.9 |
F-Score5
WACC7.26%
ROIC/WACC0.17
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
EPS Next Y31.06%
EPS Next 2Y33.47%
EPS Next 3Y33.08%
EPS Next 5Y28.34%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
Revenue Next Year-2.33%
Revenue Next 2Y0.9%
Revenue Next 3Y2.28%
Revenue Next 5Y2.57%
EBIT growth 1Y-34.7%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year933.72%
EBIT Next 3Y133.74%
EBIT Next 5Y92.11%
FCF growth 1Y-109.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.95%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%